Drug agency Suven Prescribed drugs on Friday reported a 20.35 per cent decline in its consolidated internet revenue at Rs 74.07 crore for the quarter ended September 30, 2020.
The corporate had posted a internet revenue of Rs 93 crore for the corresponding interval of the earlier fiscal, Suven Prescribed drugs mentioned in a submitting to BSE.
Consolidated complete earnings of the corporate stood at Rs 237.74 crore for the quarter into account. It was Rs 278.37 crore for a similar interval 12 months in the past, it added.
“The board has allotted the bonus shares at 1:1 ratio in its assembly held on September 29, 2020,” the submitting mentioned.
The board has authorized capital expenditure (capex) plan of Rs 600 crore conserving in view of the proposed enhance in capability in Pashamylaram facility, alternative and modernization of manufacturing blocks in Suryapet facility, relocation of R&D services from Jeedimetla and acquisition of recent applied sciences, it added.
Shares of Suven Prescribed drugs have been buying and selling at Rs 308.70 per scrip on BSE, down eight.86 per cent from its earlier shut.
(Solely the headline and movie of this report might have been reworked by the Enterprise Customary employees; the remainder of the content material is auto-generated from a syndicated feed.)
Enterprise Customary has all the time strived exhausting to offer up-to-date data and commentary on developments which can be of curiosity to you and have wider political and financial implications for the nation and the world. Your encouragement and fixed suggestions on find out how to enhance our providing have solely made our resolve and dedication to those beliefs stronger. Even throughout these tough instances arising out of Covid-19, we proceed to stay dedicated to conserving you knowledgeable and up to date with credible information, authoritative views and incisive commentary on topical problems with relevance.
We, nonetheless, have a request.
As we battle the financial impression of the pandemic, we want your assist much more, in order that we are able to proceed to give you extra high quality content material. Our subscription mannequin has seen an encouraging response from a lot of you, who’ve subscribed to our on-line content material. Extra subscription to our on-line content material can solely assist us obtain the objectives of providing you even higher and extra related content material. We imagine in free, truthful and credible journalism. Your assist by means of extra subscriptions might help us practise the journalism to which we’re dedicated.
Assist high quality journalism and subscribe to Enterprise Customary.